272 related articles for article (PubMed ID: 8302298)
1. Functional expression of human CD28 in murine T cell hybridomas.
Couez D; Pagès F; Ragueneau M; Nunès J; Klasen S; Mawas C; Truneh A; Olive D
Mol Immunol; 1994 Jan; 31(1):47-57. PubMed ID: 8302298
[TBL] [Abstract][Full Text] [Related]
2. Interelationship between CD3 and CD28 pathways in a murine T cell thymoma.
Clavreul A; Fisson S; D'hellencourt CL; Couez D
Mol Immunol; 2000 Aug; 37(10):571-7. PubMed ID: 11163393
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells.
Lorré K; Kasran A; Van Vaeck F; de Boer M; Ceuppens JL
Clin Immunol Immunopathol; 1994 Jan; 70(1):81-90. PubMed ID: 7505212
[TBL] [Abstract][Full Text] [Related]
5. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor-independent CD2 signal transduction in FcR+ cells.
Arulanandam AR; Koyasu S; Reinherz EL
J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
[TBL] [Abstract][Full Text] [Related]
8. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
June CH; Ledbetter JA; Lindsten T; Thompson CB
J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
[TBL] [Abstract][Full Text] [Related]
10. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
11. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
Van Gool SW; de Boer M; Ceuppens JL
J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
[TBL] [Abstract][Full Text] [Related]
12. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
13. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
Hueber AJ; Matzkies FG; Rahmeh M; Manger B; Kalden JR; Nagel T
Immunol Cell Biol; 2006 Feb; 84(1):51-8. PubMed ID: 16405652
[TBL] [Abstract][Full Text] [Related]
15. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma.
Zumla A; Marguerie C; So A; Yokoyama WM; Saito T; Batchelor JR; Lechler RI
J Immunol Methods; 1992 Apr; 149(1):69-76. PubMed ID: 1374780
[TBL] [Abstract][Full Text] [Related]
17. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
Walter H; Schepensn S; Van Wauwe J; de Boer M
Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
[TBL] [Abstract][Full Text] [Related]
18. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of functionally distinct human CD4+ T cell subsets.
Rotteveel FT; Kokkelink I; van Lier RA; Kuenen B; Meager A; Miedema F; Lucas CJ
J Exp Med; 1988 Nov; 168(5):1659-73. PubMed ID: 2903211
[TBL] [Abstract][Full Text] [Related]
20. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]